Grove Bank & Trust’s DexCom DXCM Stock Holding History

Grove Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.51K	Hold	67	–	–	﹤0.01%	740
2026 Q1	$4.21K	Buy	67 +8	+14%	+$557	﹤0.01%	727
2025 Q4	$3.92K	Hold	59	–	–	﹤0.01%	757
2025 Q3	$3.97K	Sell	59 -15	-20%	-$1.19K	﹤0.01%	736
2025 Q2	$6.46K	Sell	74 -1	-1%	-$78	﹤0.01%	664
2025 Q1	$5.12K	Sell	75 -69	-48%	-$5.63K	﹤0.01%	665
2024 Q4	$11.2K	Buy	144 +88	+157%	+$6.51K	﹤0.01%	519
2024 Q3	$3.75K	Hold	56	–	–	﹤0.01%	584
2024 Q2	$6.35K	Hold	56	–	–	﹤0.01%	510
2024 Q1	$7.77K	Sell	56 -49	-47%	-$6.16K	﹤0.01%	512
2023 Q4	$13K	Hold	105	–	–	﹤0.01%	466
2023 Q3	$9.8K	Buy	105 +49	+88%	+$5.52K	﹤0.01%	522
2023 Q2	$7.2K	Sell	56 -22	-28%	-$2.66K	﹤0.01%	527
2023 Q1	$9.06K	Buy	78 +68	+680%	+$7.61K	﹤0.01%	520
2022 Q4	$1K	Buy	+10	New	+$1.1K	﹤0.01%	601

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Grove Bank & Trust's DXCM Position: Q2 2026 in Review

Grove Bank & Trust held its DexCom (DXCM) position steady in Q2 2026 at 67 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Grove Bank & Trust first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. The position peaked at $13K in Q4 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Grove Bank & Trust held 67 shares of DexCom worth $4.51K as of Q2 2026.
Grove Bank & Trust left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #740 holding.
Grove Bank & Trust first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
Grove Bank & Trust's DexCom position peaked at $13K in Q4 2023.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.